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INTRODUCTION 
Collateral vessel function has not been precisely defined due to in-
complete evaluation of the hemodynamic changes which take place during 
collateral vessel recruitment and function. Many factors influence col-
lateral hemodynamics during arterial stenosis and thrombosis. In this 
study, an attempt will be made to measure some of these parameters and to 
determine if the vasodilators acetylcholine (ACh) and prostacyclin ( PGI2 ) 
may improve collateral circulation during arterial thrombosis. 
In many tissues, the arterial vasculature is designed to maintain 
nutrient supply during arterial occlusion. During occlusions, a network 
of preformed anastomosing arterial branches called collateral vessels 
supply nutritive blood flow to areas previously fed by occluded parent 
arteries. 
Collateral vessels have been classified as stem, midzone, and reen-
trant vessels, depending on their location relative to an occlusion 
(Longland, 1953). The most proximal elements, stem vessels, supply blood 
to the midzone vessels, which are composed of a multitude of channels 
normally invisible in arteriographs (Winblad et al., 1959 ) . Although 
midzone vessels have a high resistance, they can enlarge to allow blood 
flow into the distal elements, reentrant vessels. 
During an arterial occlusion, reentrant vessels may conduct retro-
grade blood flow into the parent vessel distal to the occlusion, thus 
supplying sufficient blood to the tissues distal to the occlusion to keep 
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them viable. The degree to which the viability of the distal ischemic 
bed is maintained is a functi on of the extent of collateralization, how 
rapidl y an occlusion develops, vascu l ar tone, the location of arterial 
occlusion relative to the distribution and size of the collateral ves-
sels, and the metabolic rate of the ischemic bed tissue. 
Occlusion of an artery is not a simple mechanical event . It causes 
tissue ischemia and endothelial cell damage , which result in the release 
of vasoacti ve substances (Imhoff , 1961) . Two such substances known to be 
released during t hrombot ic occlusion, serotonin (Kordenat and Kezdi , 
1979) and t hromboxane A- 2 (TXA2) (Schaub et al., 1982) , regulate blood 
flow to distal tissues and may cause tissue death following an occlus i ve 
incident (Schaub et al., 1977a, 1977b). 
Previous studies of col lateral blood flow (CBF) have generated 
severa l observations about their functions. It wa s observed that the 
resistance of a stenosis is dynami c and is interdependent upon peripheral 
and collateral bed hemodynamics (Roth et al. , 1976 ; Wallinsky et al ., 
1979). Mechanical occlusion (stenosis ) produced the greatest stimulus 
for CBF (Winblad et al ., 1979), wh i le the presence of an intravascular 
arterial thrombosis inhibits development of CB F (Schaub et al ., 1976, 
1977a, 1977b) . Strenuou s exercise is the onl y documented therapeutic 
method to improve CB F during a mechani cal occl usion (Thul esius , 1963; 
Khudaiberdyerv and Kuli kov, 1970). 
Thi s study wa s designed to monitor and analyze hemodynamic variables 
whi ch interact to influence collateral vessels; to compare stenosis with 
and without the effec t s of thrombosis at the same vascular site; and to 
xii 
determine the effects of ACh and PGI2 on CBF. By utilizing t he hi nd limb 
of the dog as a model, a more comprehensive experimental design has been 
incorporated in this study than in previous experimental models. 
1 
REVIEW OF LITERATURE 
Vascular disease in which nutritional blood flow to a body region has 
been compromised is a co111T1on problem in medicine today. Arterial throm-
bosis has been fo und to be one of the acute manifestations of a vascular 
disease which reduce or interrupt normal blood flow to a region . 
In order to better understand the mechanisms involved in promoting 
survival of an organ or tissue during thrombotic insult , the study of 
collateral blood flow {QC) is warranted, and further investigation may 
provide valuable knowledge. 
Stenotic Factors Which Affect Normal Blood Flow 
Artificial stenoses have been employed in major nutrient arteries 
(arteries supplying nutritional blood flow to tissues) by many investiga-
tors in order to study impairment of circulatory function (Mann et al., 
1938; Folts et al. , 1974; Kubicka et al., 1979) . During these experi -
ments, the cross - sectional area of a vessel was reduced to study the 
relationship between lumen reduction or length of the stenotic segment 
and the degree of inhibition of blood flow. 
In the carotid artery of the dog, the cross-sectional area (the area 
of a section at right angles to the lumen of the vessel) of the lumen was 
reduced 50% by insertion of an 8 mm long bakelite tube with an appropri-
ate internal diameter without modifying blood flow through the artery. A 
90% lumen reduction depressed blood flow by 50% (Mann et al . , 1938) . 
Other investigators found that significant flow reduction through the 
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vessel by insertion of 2 mm long plastic cylinders of varying internal 
diameters within a coronary artery did not occur until 78% reduction of 
luminal cross-sectional area was achieved (Folts et al ., 1974). Kubicka 
et al. (1979) first noticed flow decreased with 75% reduction of lumen 
cross - sectional area. A 98% cross-sectional area reduction dropped ves -
sel blood flow to 25% of its original value . Kubicka inserted a double 
limb extracorporeal shunt into the right common iliac artery of five 
dogs. One limb of the shunt maintained blood flow to the leg between 
maneuvers. The second limb of the shunt was constructed to allow place-
ment of 1 cm long inserts, from 4 mm to 0.5 111n in internal diameter, in 
order to produce repeatable, progressive arterial stenoses . Flow pro xi-
mal to the shunt was measured by the electromagnetic blood flow (EMF) 
technique following each progressive stenosis. Measurements were made 
with the circulation intact, then repeated following ligation of major 
collateral arteries such as the median sacral, internal iliac , and pro -
funda femoris. Reduction of the number of potential collateral vessels 
did not affect the maximum blood flow observed by progressive arterial 
stenos is. 
Percent decrease in cross-sectional area was an incomplete measure of 
the degree of a stenosis as found by Gould (1978 ) . He stated that 
stenosis geometry modified resistance, pressure differential (6P) , and 
flow reserve capacity of a vascular bed. Flow reserve refers to maximum 
flow rate which is achievable during oxygen deficit following a period of 
complete occlusion. Young and Tsai (1973 ) in their experiments found 
that stenosis geometry, in addition to flow turbulence and separat ion, 
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determined pressure drops across stenoses. Roth et al. (1976) and Young 
(1979) described factors other than stenosis geometry which modify vascu-
lar hemodynamics in critical stenoses. They stated that stenosis resis-
tance (RS) was not fixed but rather dynamic in nature. When the pressure 
gradient was held constant, a change in RS was primarily determined by 
collateral circulation and peripheral resistance (RP). Gould et al. 
(1975) also showed that the resistance of a fixed stenosis could be vari-
able; a decrease in RS increased flow through the stenosis ( R=~P). 
Q 
Stenosis length is another factor influencing blood flow. A four-
fold increase in length of a critical stenosis produced a 25% reduction 
in flow (May et al., 1963). A stenosis is "critical" when a small de-
crease in lumen size is associated with appreciable reduction in blood 
flow. There was no effect of stenosis length upon blood flow during sub-
critical periods. Feldman et al. (1978) found that smaller decreases in 
cross-sectional area were necessary to reach critical stenosis when 
stenosis length was increased. In addition, it was found that stenoses 
in series produced additive effects. These findings were supported by 
results of Gould and Lipscomb (1974) and Young (1979) . 
It appears that RS is not static and could increase when the distal 
vascular bed dilated due to release of vasoactive substances (Wallinsky 
et al., 1979). In a stenosis less than 100%, RS through the section up-
stream from a peripheral bed wa s a function of the sum of the resistances 
of the two elements when collateral flow (QC) was absent (please refer to 
Figure 2), QP = PA-PV. Kreuzer and Schenk (1973), along with Schwartz et 
RS+RP 
al. (1980), found that at constant driving pressure distal vasodilation 
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reduced RP, thus increasing QS and elevating RS . In a later study, 
Schwartz et al. (1980) observed that a lowering of coronary pressure 
proximal to the stenotic segment increased RS due to passive narrowing of 
the vessel from elastic recoil. Investigations by Santamore et al. 
(1980) and Wallinsky et al. (1979) agreed with Schwartz's findings that 
proximal vasoconstriction greatly increased stenosis severity . Such a 
passive narrowing could occur physiologically in or due to a tissue isch-
emia, thus depressing arterial pressure there and perhaps promoting 
vasodilation distal to the stenosis. 
While 6P and Qare the primary determinants of RS, both RC and RP 
also can be effective modulators of RS . All of the hemodynamic 
parameters are variable and are interdependent (RS on QS and 6P; RS on RC 
and RP). Over the course of a long-term experiment, all variables are 
dependent upon anesthesia, surgery, physiological deterioration, and sys-
temic buildup of extrinsic vasoactive agents. 
Cardiovascular Occlusive Disease and Thrombosis 
Prolonged or repeated occlus ion of the arterial inflow to a tissue 
bed may endanger tissue function and viability. Impaired function is 
seen most frequently in tissues experiencing mechanical limitations of 
blood flow. These limitations can be due to compression, to thromboem-
bolism, or to arterial occlusive disease. Dysfunction occurs when tissue 
oxygen demand exceeds oxygen supply as in peripheral arterial occlusive 
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disease, which annually debilitates many patients and re su lts in pro-
longed and extensive morbidity and may result in loss of life. 
Vasodilator drugs have been used in pharmacotherapy of peripheral 
arterial occlusive disease. Their efficacy in restor i ng circulation to 
ischemic tissue beds has been limited . Adrenergic blocking agents have 
been successfully used in the treatment of occlusive peripheral vascular 
disease; however, they possess several untoward effects which limit their 
usefu lness. 
Beneficial peripheral effects of alpha receptor blocking agents, 
e.g ., phenoxybenzamine and methysergide maleate, may be overshadowed by 
systemic effects leading to refle x tachycardi a and electrocardiogram 
modification. They promote systemic hypotension and may produce periph-
eral vascular insufficiency (Bergersen and Goth, 1976); therefore, the 
use of these agents is questionable. 
The ergot alkaloids, mild alpha blockers, have been contra indicated 
in treatment of per ipheral occlusive vascular disease due to powerful 
vasodilatory actions unrelated to their antiadrenergic properties (Gilman 
et al . , 1980) . The flow distribution to the already malperfused, isch-
emic region(s) could be compromised by active dilation of the blood ves-
sels elsewhere . 
Pharmacologic agents suitable for modulating the distribution of 
blood flow between prestenotic/thrombotic areas and the collateral-
dependent areas ideally should not produce untoward effects on the sys-
temic circulation, blood pressure regulation, and cardiac function. 
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Experimental Arterial Thrombosis 
Experimental thrombosis models have been studied in order to more 
fully comprehend the nature of va soacti ve substances released during car-
diovascular occlusive diseases . Kingsley et al. (1967) stated that inju-
ry produced from roughening the intima of the arterial wall is a factor 
in the promotion of thrombus formation. Sheppard and French (1971) in-
serted and rotated a roughened metal probe within the aorta of several 
rabbits. Within 45 minutes after removal of the probe, platelet aggrega-
tion was observed at the injury site. 
Many investigators employed electrical stimulation to disrupt the 
intimal lining of arterial vessels and encourage thrombosis (Duval et 
al., 1970; Piton et al., 1978; R.omson et al., 1980; Sedlark et al., 
1980). 
Gianturco et al. (1975) induced a gradually forming arterial throm-
botic occlusion in man. Their technique was recoJTmended in a clinical 
trial but was not performed experimentally. They employed a stainless 
steel coil and Dacron tuft which induced a thrombus plug to form. 
Szarnicki et al. (1981) employed this same device for transcatheter 
embolization of major systemic pulmonary arterial collateral vessels in a 
human patient for correction of pulmonary atresia. In the Szarnicki 
study, a stainless steel wire coil with a Dacron tuft attached to its 
inside diameter was integrated into a "loading cartridge" arrangement. 
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The loading cartridge was advanced through an angiographic catheter pre-
cisely placed fluoroscopically and released from the catheter at a pre-
viously determined site. After the coil wa s extruded from the catheter 
tip, it assumed a helical shape with the Dacron tuft enmeshed in the wire 
coil. Proper sizing of the coil wa s determined by the diameter of the 
vessel to be embolized. The risk of distal embolization was minimized 
with the correct coil size. Rapid thrombus formation occurred and a plug 
formed at the precise placement site . Angi ograms were taken to document 
complete vessel occlusion. 
Kordenat et al. (1972 ) and Kordenat and Kezdi (1979 ) produced gradua l 
coronary arterial thrombosis in a canine model by insertion of a hel i cal 
copper coil within the lumen of a coronary ves sel. This technique, with 
several modifications, wa s our method of choice {please refer to the sur-
gical procedure section). 
The thrombotic occlusion model used by Ko rdenat to produce a slowl y-
forming thrombus consisted of precisel y placing a helically-shaped coil 
of copper wire (thrombogenic) into a selected co ronary arterial bra nch . 
The animals were anesthetized lightly with sodium pentobarbital , and a 
concentric, double lumen catheter wa s utilized to insert the coil into 
the artery. In this technique, the tip of the inner catheter, upon which 
the wire coil had been emplaced, wa s inserted into the left anterior de-
scending coronary artery (LAD ) . The wire coi l wa s directed into the LAD 
under fluoroscopic (image intensifier) visualization. By pull ing the 
inner catheter back wh i le holding the outer cathete r stationary, the end 
of the outer catheter pushed agai nst the wire coil and it was released 
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into the LAD. The copper wire coil, of sufficient size to become fixed 
in the LAO, was approximately 1.5 to 2.0 ITIT1 in overall diameter and 5 to 
7 1T1T1 long. The occluding thrombus began to form immediately and was com-
plete 15 to 20 minutes after the wire coil was inserted . Coronary blood 
flow via the LAD became successively depressed. Complete occlusion was 
confirmed electrocardiographically (S-T segment configuration changes) 
and angiographically. The gradually occluding intracoronary thrombus 
produced experimental infarction. This thrombosis model simulated coro-
nary thrombosis without pre-existing arteriosclerosis in man (Kordenat 
and Kezdi, 1979). 
Van Aken et al. (1980) and Barnes (1981) proposed that collagen may 
induce intravascular platelet aggregation and thrombosis. Van Aken in-
verted a fl~p of the aortic wall into the lumen of rats to expose blood 
to collagen and thus produce thrombosis. In a similar fashion, Constan-
tine et al . (1972) inverted a segment of a side branch of the carotid 
artery in dogs to produce thrombosis. 
Collateral Blood Flow 
The first report of the existence of CF was in 150 by Antyllus, a 
Greek surgeon who observed that vessel ligation did not always result in 
damage to the perfused area (John and Warren, 1961). Lower in 1669 and 
Haller in 1757 documented the presence of anastamosing blood vessels in 
the heart (John and Warren, 1961). Continued growth of a stag's antler 
after main nutrient artery ligation in a study by Hunter, cited in John 
9 
and Warren (1961), focused interest upon and promoted further research 
into collateral vessel development. 
The mechanisms for recruitment of QC and the impetus for recruitment 
of collateral vessels still are not clearly defined. Previous studies 
have shown controversial results. 
Dornhorst and Sharpey-Schafer (1951) measured a significant decrease 
in collateral bed vascular resistance associated with arterial occlusion 
by clamping the femoral artery in the dog. The decrease was thought to 
be the result of depressed sympathetic vascular tone and increased pres-
sure gradients resulting from the occlusion, which may have initiated the 
release of vasodilator substances. Their findings were supported by Im-
hoff (1961). He stated that the simpl e occlusion of the distal feline 
aorta (without thrombus formation) resulted in the release of vasoactive 
agents from the blood vessel and tissues distal to the occlusion, the 
release of these substances being associated with the initiation of CF. 
Berne (1970) concluded that adenosine and other vasoactive substances may 
have been responsible for peripheral vasodilation distal to the occlu -
sion. A three-fold increase in blood adenosine levels was detected from 
tissues distal to an occlusion site (Olsson, 1970). Proposals that 
adenosine in ischemic tissue regions promotes collateral vessel vasodila-
tion were supported in a later study by Berne (1980). 
Coffman (1966) found genesis of QC was dependent upon predominant 
vasomotor tone and the existing state of vascular reactivity. Studies by 
Theis (1933) and Donald and Ferguson (1970) supported Coffman's conclu -
sions with the discovery that sympathectomy enhanced collateral blood 
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flow, but experiments conducted by Rutherford and Valenta (1971) and All-
wood (1962) found that sympathectomy did not improve QC. 
Some have stated that following occlusion, increased pressure dif-
ferentials and flow velocities were the predominant stimuli for col-
lateralization (Longland, 1953; Winblad et al., 1959; John and Warren, 
1961; Leibow, 1963; Giron et al ., 1971; Barnes, 1980). 
One of the most notable observations with respect to recruitment of 
CF was that strenuous exercise markedly improved post-occlusion CF 
(Khudaiberdyerv and Kulikov, 1970; Rutherford and Valenta, 1971; 
Thulesius, 1963; Abramson, 1980; Fedor et al., 1980). After exercise 
training, patients with occlusive disease exhibited improved circulation 
to affected extremities over that of the pre-exercise period . 
Earlier, the benefits of exercise upon QC in the human subject had 
been subject to doubt. Allwood (1962) found that during exercise of the 
calf muscles in the subjects with occlusive vascular disease, CF to the 
foot and calf was diminished. Closure of small blood vessels due to re-
distribution of blood flow during exercise wa s suggested as the reason. 
When blood is directed away from a region of the body, driving pressure 
in the peripheral blood vessels may decrease. This decreased in-
traluminal pressure changes the tension exerted on the arterial wall by 
the smooth muscle in the wall and may allow the radius of small vessels 
to decrease. As hypotension progresses, a vessel's caliber could de-
crease progressively until it reaches critical closi ng pressure, at which 
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time the lumen completely closes. It is more probable that decreased 
vascular resistance elsewhere is the reason that the dependent vascular 
bed is deprived of blood flow. 
Thrombus Inhibition of Collateral Blood Flow 
Imhoff (1961) and Schaub et al. (1976, 1977a, 1977b ) noticed only 
transient inhibition of pre- existing collateral vessels during simple 
ligation of the feline distal aorta. Ligation of the terminal aorta in 
Imhoff's study produced transient hind limb reflex abnormalities, but 
aortic occlusion by an experimentally induced blood clot resulted in hind 
limb paralysis, rear extremity hypothermia, and lack of a femoral pulse. 
Schaub similarly studied the responses of feline hind limb collateral 
circulation in two models of aortic occlusion : simple ligation and 
thrombus formation. For the simple ligation model, the caudal aorta was 
permanently ligated approximately 5 mm distal to the origin of the caudal 
mesenteric artery. The sixth lumbar arteries and the left deep circum-
flex iliac artery were ligated. Ligatures were secured around the right 
deep circumflex iliac artery and the aorta at the level of the trifurca-
tion at the external iliac arteries. After evacuation of the blood from 
the aorta, the ligatures were tightened. The blood was evacuated by 
flushing the aorta with 37oc saline solution or by digital evacuation 
prior to tightening the ligatures. 
Hemodynamic responses following simple ligation then were compared 
with those following thrombotic occlusion of the caudal feline aorta 
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(Schaub et al., 1976, 1977a, 1977b). In the thrombus occlusion model, 
experimental occlusion of the aorta by thrombosis was produced by tem-
porarily ligating the aorta approximately 5 IM1 distal to the origin of 
the cauda l mesenteric artery . The right and left deep circumflex iliac 
arteries were acutely ligated as were the sixth lumbar arteries . The 
aorta was ligated at the trifurcation after positioning a 16 gauge needl e 
within it . The temporary ligation was removed allowing blood to enter 
the region, then the aorta was occluded again. Ten to 20 units of 100 
µ/ml of thromboplastin were injected into the trapped blood , causing a 
clot in a 1. 5 cm segment of aorta. The needle then was removed . 
Postsurgically, all ligation cats treated in Schaub's studies ini-
tially showed depression of reflexes, demonstrated by ataxic gait and 
hind limb muscular weakness. After three days, however, all reflexes 
improved and only slight gait impairment was noticed . Aortog rams indi-
cated substantial blood flow adjacent to the area of aortic ligation, and 
the fifth and seventh lumbar vessels appeared dilated compared to the 
anterior lumbar vessels . 
Cats subjec ted to aortic thrombosis had severely depressed or absent 
reflexes after recovery from anesthesia. Three days after occlusion, 
these subjects exhibited no improvement in neurological reflexes , and 
aortograms showed a lack of collateral vessel development. 
Thus, occlusion by blood clot appeared to have impaired caudal blood 
flow to greater degree than did simple ligation and resulted in hind limb 
paralysis . Schaub et al. (1977a, 1977b) proposed that while the thrombus 
did not provide any greater mechanical impairment to blood flow than did 
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the simple ligation model, the release of vasoconstrictor substances by 
the thrombus was the cause of the more extensive impairment of collateral 
flow. 
The release of a vasoconstrictor substance from aggregated platelets 
was suggested in an earlier study by Zucker (1947), who observed that 
vasoconstriction occurred not only in injured, platelet -containing blood 
vessels, but also in adjacent vessels. This adjacent vasoconstriction 
did not appear to be due to trauma or reflex, thus implicating vasoactive 
agents released by the platelets. 
Schaub et al. (1977a, 1977b) suggested that serotonin was the vasoac-
tive agent released by aggregating platelets or vessel endothelium which 
inhibited collateral blood flow by inducing vasoconstriction. Serotonin 
may reduce QC by its direct vasoconstrictive action on vascular smooth 
muscle. He reported that treatment with reserpine or para-
chlorophenylalanine (p-CPA), both serotonin antagonists, improved col-
lateral circulation to the feline hind limbs following clot formation in 
the descending aorta. Later Schaub et al. (1982) added that it was more 
probable that recirculation of platelet-derived thromboxane-A2 (TXA2) 
provided the impetus to depress QC. (Please refer to the section enti-
tled "Prostaglandins and the Prostacyclin-TXA2 Interactions".) Perhaps 
other agents besides serotonin and TXA2 may mediate post thrombotic in-
hibition of CF . 
The exact mechanisms of action for the vasoactive agents affecting CF 
have not been defined; vasoconstriction, platelet aggregation, or en-
dothelial cell damage have been postulated (Schaub et al., 1977a, 1977b). 
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To date, the most definitive method for evaluating improvement of CF by 
therapeutic agents appears to be an arterial thrombosis model (Schaub et 
al • , 1977 a, 1977 b). 
Prostaglandins and the Prostacyclin-TXA2 Interactions 
In this section, the role of prostaglandins and other autocoids in 
regulating local blood flow will be discussed. The prostaglandins, by 
their various actions, have been established as physiological mediators 
of blood flow regulation. A number of unstable but highly active inter-
mediates have been isolated and characterized (please refer to Figure 1 
for a diagram of the sequence of events leading to the release of vasoac-
tive endoperoxides which regulate local blood flow). 
PGAl, PGEl, and PGBl were found to have vasodilatory effects in man 
and experimental animals (Goodman and Gilman, 1975). Dusting et al. 
(1978} investigated the vascular actions of arachidonic acid and its 
metabolites in perfused femoral beds in the dog, PGI2, PGE2, PGH2, and 
arachidonic acid induced vasodilation. PGI2 had an acute vasodi l atory 
effect over five minutes in duration with a prolonged recovery period. 
The femoral bed was more sensitive to PGE2, and this dilator was 2-15x 
more potent than PGI2. PGH2 wa s of equal potency to PGI2, but its dura-
tion of action was shorter. 
TXA2 is formed in the platelets and causes vasoconstriction (Bunting 
et al., 1976; Needleman et al., 1976} and platelet aggregation (Harker 
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and Slighter, 1972; Moncada and Vane, 1977 ) . Dusti ng et al. (1978) ob-
served vasoconstrictor effects from PGF2- «, TXA2, and the endoperoxide 
analog UH6619. PGF2-« was a weak vasoconstrictor. TXA2 was more effec-
tive in the mesenteric than in the femoral vascular bed, although its 
action lasted less than two minutes . Studies by Harrmarstrom and Falar -
deau (1977) and Hamberg et al . (1975) suggest that TXA2 stimulates the 
release of serotonin, a powerful vasoconstrictor of vascular smooth mus -
cle, from blood platelets. 
PGI2 is formed in arterial and venous walls and acts to promote 
vasodilation wh i le inhibiting platelet aggregation (Gryglews ki et al., 
1976; Bunting et al., 1976; Tateson, 1977; Moncada and Vane, 1978). Mon-
cada and Vane hypothesized that endoperoxides released by the platelets 
were converted to PGI2 in the microsomal fraction of the intimal cells. 
The PGI2-TXA2 Interaction 
Two of the most prominent hormones i n modulating vessel caliber and 
blood clotting are PGI2 and TXA2. These prostaglandins are synthesized 
endogenously in the arterial and venous intima and within blood platelets 
(Goodman and Gilman, 1975). Though TXA2 and PGI2 both are formed from 
arachidonic acid via the endoperoxidase system, they have opposite ac-
tions (Harrmarstrom and Falardeau, 1977; Gorman, 1979). Their reciprocal 
actions provide a mechanism for regulation of local blood flow within the 
body . 
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Numerous experiments suggest that control of thrombogenesis is due to 
a balance between blood levels of PGI2 and TXA2 (Gryglewski et al., 1976; 
Moncada and Vane, 1978; Pace-Asciak, 1977; Dusting et al., 1978). Inves-
tigations by Miller et al. (1977) showed that TXA2 acted on platelets by 
depressing cAMP levels. Tateson et al. (1977) and Moncada and Vane 
(1978) observed that PGI2 promoted increased cAMP levels in platelets. 
Gorman (1979) further delineated the mechanism behind the PGI2-TXA2 
interaction. He stated that TXA2 inhibits adenylate cyclase which de-
presses cAMP levels and promotes calcium release from platelets, causing 
their aggregation. Conversely, PGI2 activates the adenylate cyclase sys-
tem, stimulating high levels of cAMP and sequestering calcium within the 
platelets, thus preventing aggregation. It appears that TXA2 and PGI2 
have opposing effects on platelet cAMP levels, giving a controlled 
balance system in the regulation of vascular haemostasis (Moncada, 1980). 
Selective inhibitors of TXA2 or PGI2 have been used to elucidate the 
degree and direction of control exhibited by these two hormones on plate-
let behavior and vasomotor tone. Inhibition of PGI2 resulted in in-
creased platelet aggregation, due to predominant TXA2 effects. Inhibi-
tion of cyclooxygenase by indomethacin or meclofinamate promoted the 
vasoconstrictive effects induced by TXA2 (Dusting et al., 1978). These 
agents may prevent endogenous prostacyclin synthesis in the vasculature, 
thus enhancing TXA2-mediated vasoconstriction by reducing the counteract-
ing vasodilation by endogenous PGI2. 
During thrombosis, release of TXA2 by platelets has been shown to 
occur, resulting in vasoconstriction and platelet aggregation (Moncada 
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and Vane, 1978). Intra-arterial injection of prostacylin may counteract 
the constrictor effects of TXA2, may inhibit platelet aggregation, and 
may promote collateral perfusion to a thrombotically occluded vascular 
bed (Moncada and Vane, 1977). Antagonism of TXA2 formation led to a pro -
longed bleeding time and promoted vasodilation due to the prevailing ac -
tions of PGI2 (Nijkamp et al., 1977; Moncada, 1980). 
PGI2, a circulating hormone that is not degraded significantly in the 
lungs as are many other prostaglandins, has a half-life of 30-40 minutes 
(Dusting et al., 1978). In this study, we attempted to use PGI2 to pro-
mote collateral blood flow during thrombosis. 
Acetylcholine (ACh) 
ACh was chosen as the second vasodilatory agonist in this project 
because it is a well-known, powerful vasodilator and has a very brief 
duration of action (5-7 minutes), an advantage when several agents are to 
be infused consecutively. 
In the canine femoral artery, the response to ACh was reached within 
20 to 50 seconds after the beginning, and lasted for 5 to 7 minutes after 
the cessation, of a continuous infusion (Mons et al., 1970). The dila-
tion response was independent of retrograde propagation of nervous or 
myogenic impulses along the vascular wall, which implied local control 
was exerted. ACh causes vasodilation by stimulating muscarinic receptors 
on those vascular beds having postglanglionic parasympathetic effector 
ce 11 s. 
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MATERIALS AND MET HODS 
Experimental Design 
A collateral system of vessels supplies blood to the ischemic lower 
hind leg peripheral bed during partial or complete occlusion of the FA. 
Figure 2 depicts circulation of the canine lower hind limb. Arterial 
thrombosis has been shown to inhibit collateral blood flow development 
more than simple ligation (Schaub et al., 1976). It has been proposed 
that a thrombosis may modulate the level of ischemia in a distal tissue 
by releasing either adenosine (Berne, 1970), prostacyclin (Moncada, 
1980), serotonin (Schaub et al., 1977a, 1977b), or TXA2 (Schaub et al., 
1982). 
In this study, acute stenosis and thrombosis of the FA were compared 
in their abilities to affect collateral blood flow. An attempt was made 
to improve collateral blood flow during thrombosis by infusion of the 
va sodil ators ACh and PGI 2. ACh, a well-known vasodilator, was chosen due 
to its short duration of action. PGI2 was utilized for its ability to 
promote col lateral blood flow by inhibiting the vasoconstrictor effects 
of TXA2 and preventing platelet aggregation in a vascular bed downstream 
of a thrombosed artery (Moncada and Vane, 1978). The mechanisms of ac-
tion of ACh and PGI2 are different; each was discussed in the Review of 
Literature. 
While four animals provided the data reported in this study, an addi-
tional six were utilized in pilot trials to develop surgical procedures 
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Figure 2. Diagram of the major arteri es and some of the potential 
collateral vessel s in the canine hind l imb (r eproduced 
f rom Anatomy of the Dog by Mill er et al., 1977 ) 
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and to calibrate the measurement systems, and three for perfecting the 
sequence of administration of RM. 
Each animal was subjected to five treatment periods. The treatments , 
in order of initiation, were 100% stenosis (100-S) , 0% stenosis (O-S) or 
control, thrombosis (Th ) , thrombosis with ACh infus ion (Th+ACh) , and 
thrombosis with PGI2 infusion (Th+PGI2) . 
The order i n whi ch the experimental flow states were induced could 
not be randomized fo r several reasons. The 100-S regimen preceded the 
0-S (control) period because it in itself established a flowmeter zero 
reading for QS during the control period. During 100-S, flow was con-
side red to be free · from the effects of vasoactive agents. Both 100- S and 
0-S states had to be implemented before inducing the third experimental 
state, Th, since this state was irreversible once the thrombus wa s 
formed. After thrombosis was verified both visually and by reduction of 
QS to essentially zero and after the Th circulatory parameters were mea -
sured, collected, and stored , ACh infusion wa s started. When the 
respo nse to ACh infusion stabilized , the Th+ACh period was identified and 
data were recorded. 
Since the duration of action of ACh is short and transitory , appro xi-
mately 5-7 minutes after the cessation of a continuous infusion (Mons et 
al. , 1970) , the evaluation of the second agent, PGI2, was possible if a 
reco very period of approximately 10 min- utes was i nstituted . It was 
infused as the final step in the experimental cyc le (Th+PGl2) because of 
its relatively long duration of action, appro ximately 30 to 40 minutes 
(Dusting et al., 1978 ) . 
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Pressures and flows were measured during each experimental period. A 
list of formulae used to calculate the experimenta l parameters is pro-
vided in the Appendix. Radioactive microspheres (RM}, 15µ in diameter, 
were injected during each circulatory state in order to determine periph-
eral and collateral blood flow to the lower hind limbs , arteriovenous 
shunti ng, and total kidney blood flow. Tissue samples were collected for 
subsequent analysis for determination of peripheral blood flow by the 
radioactive microsphere technique (RMT) at the conclusi on of each 
experiment. 
Protocol for Implementing the Experimental Design 
To induce the 100-S state, a vascul ar (bulldog} clamp was placed on 
the left FA approximately 4-6 cm above the origi n of the saphenous artery 
(SA) and app roximately 2 cm downstream from the EMF probe , between the 
sites for measurement of P1 and P2 (Plates 1 and 2) . Blood flow and 
pressures were allowed to equilibrate, and EMF blood flow and arterial 
and venous pressures were recorded . Immediately after sampling, 46sc-
labelled RM (15 µ) were injected into the left ventricle (LV) . After 
reference blood samples were withdrawn from the aortic and external 
thoracic arterial ca nnulae (according to Heymann et al., 1977), the vas-
cula r clamp was removed and the hind leg ci rculation was allowed to 
equilibrate. 
For the 0-S determination (control level), 118sn-labelled RM (15µ) 
were injected into the LV immediately after EMF flow and blood pressures 
Plate 1. The surgical incision for isolation of the left 
femoral artery and saphenous artery 
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a) Femoral Artery 
b) Saphenous Artery 
c) Femoral Vein 
Plate 2. The EMF probe and the vascular occluder in place on 
the femoral artery with the copper coil device 
emplaced within the femoral artery 
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a) EMF Probe 
b) Femoral Artery 
c) Thrombogenic Copper Coil Device 
d) Pl 
e) P3 
f) P2 
g) Pneumatic Vascular Occluder 
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were measured. After recording 0-S flow parameters, the FA was double 
clamped and a transverse incision was made in the left FA at the pre-
viously described stenosis site . To induce thrombosis, a polyvinyl tube 
15 mm in length and 4 to 5 mm in diameter, heat-shrunk over a thrombus-
inciting copper coil, then was inserted into the vessel lumen. The 
thrombogenic device was constructed by tightly coiling a thin copper 
wire, .005 mm in diameter, around a mandrel 2.0 to 3.0 mm in diameter. 
After this was done, a length of heat shrink polyvinyl tubing was secured 
around the copper coil. This thrombogenic device was trimmed to 15 mm in 
length and then removed from the mandrel. Thus, the copper wire coil was 
firmly attached i nside the leak-proof polyvinyl tube, and, once implanted 
in the FA, it would be exposed to flowing blood (Figure 3) . The copper 
wire initiated blood clotting and thrombus formation within the lumen of 
the thrombogenic device (Kordenat et al., 1972; Kordenat and Kezdi, 
1979). Ligatures were installed around the vessel and tube above and 
below the incision site in order to prevent hemorrhage, and then the oc-
clusions were released, thus allowing blood to flow through the coil. 
Within 30 to 60 minutes after insertion of the copper coil, a complete 
thrombotic occlusion of the FA (verified visually and by EMF measure-
ments) had resulted (the Th state). After the thrombus had formed, pres -
sures and zero flow were recorded and 85sr-labelled RM (15µ) were 
injected. 
Immediately after these measurements were completed , ACh was infused 
(Sigma Chemical Co ., St. Louis, Mo.; 0.123 ml/min, 500 mg/ml) in the 
aorta. After the response to the ACh had equilibrated, circulatory 
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Copper coi 1 
Polyvinyl tube 
Figure 3. Exploded view of the copper coil device implanted 
within the left femoral artery to induce thrombosis 
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parameters were recorded (Th+Ach), then 95Nb-labelled RM (15µ) were in-
jected . After all measurements were completed, the ACh infusion was dis-
continued and circulatory parameters were allowed to equilibrate . 
Finally, the sodium prostacyclin infusion (Burroughs Wellcome Co., 
Research Triangle Park, NC) was started and maintained at a rate of 0.494 
ml/min (4,000 µg/ml) until hemodynamic parameters stabilized, then 141ce 
microspheres (15µ) were injected. These were recorded once this state 
(Th+PGI2) was established. 
In order to standardize experimental procedure , the same isotope was 
used for each stage of the experiment in all subjects, hopefully imposing 
equal hemodynamic effect. 
Pressure and Flow Relationships 
Blood pressures were measured at the following locations: 
PA: Mean arterial blood pressure in the distal abdominal aorta , above the 
origin of the conmon iliac arteries and the several smaller arteries 
which supply driving pressure to the hind limb collateral vascular 
bed . 
P1: Mean arterial blood pressure in the FA proximal to the stenosis 
(driving pressure for flow through the stenosis). 
P2: Mean arterial blood pressure in the FA distal to the stenosis. 
P3: Mean arterial blood pressure measured through a catheter direct-
ed downstream in the saphenous artery. This variable estimates 
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the driving pressure for the peripheral bed during Th, Th+ACh, 
and Th+PGI2 treatment periods. 
PV: Mean venous blood pressure in the femoral vein (venous blood 
pressure). 
Equations and Diagrams 
The following equations were used to calculate vascular resistance at 
the femoral artery stenosis site (Rs) and in the collate ral (Re) and pe-
ripheral (Rp) vascular beds. 
Rp = 
P2-PV 
Qp 
Re = Pa-P3 
QC 
Dimensions of these variables are: 
p (Pressure) = mm Hg 
Q (Fl ow) =ml ·min-1 
R (Resistance) = mm Hg·min·m1-l 
A schematic representation of the experimental model with sites of 
pressure and flow measurement is shown in Figure 4. 
31 
~-AORTA 
__.......... coNTRALATERAL LEG 
FA-
! 
PA 
OPC 
Pl 
EMF ! QC 
RS RC 
P2 
THIGH 
LOWER HINDLEG ! ______ _.,a P3 
RP 
PV 
Figure 4. Schematic representation of the canine hind limb with various 
resistive vascular components and sites of pressure and flow 
measurements 
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Measurements 
Blood flow measurement 
Peripheral blood flow (QP) is a measure of the volume of blood 
returning from the hind leg distal to the proximal caudal femoral vein . 
The RMT was used to measure QP; this technique will be explained later in 
this section. 
Collateral blood flow (QC) was ca lculated to be the difference 
between QP and QS, QC = QP - QS. When the FA was occluded by mechanical 
means or by complete thrombus formation, then QC = QP. 
EMF blood flow measurement 
Blood flow through the FA (QS) was measured by a 3 mm noncannulating 
EMF transducer (Model 4, In Vivo Metric Systems , Healdsburg, CA) with an 
electromagnetic flow measuring system (Biotronix Model BL 610, Chicago , 
IL). Please refer to Plate 2 for a photograph of the EMF probe in place . 
Before beginning each experiment, the "cal" mode output of the EMF 
module, a reference voltage of 0.8 volt approximately equivalent to 150 
ml/min., was utilized to adjust recorder sensitivity so that subsequently 
recorded blood flow experimental data fell within the recording range of 
the polygraph. 
The actual calibration of the EMF system was accomplished just prior 
to the termination of the experiment. The EMF transducer was calibrated 
in situ on the FA over a range of flow rates from 10 to 250 ml/min. The 
setup consisted of inserting a cannula into the FA distal to the EMF 
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probe. Blood was pumped by the dog's heart into a graduated cylinder by 
timed collection. Flow rate was controlled by a screw clamp on the 
tubing . The regression equation to relate flow and the polygraph and 
computer voltage outputs was developed from 4 to 5 flow rate measurements 
for each EMF transducer across the flow range to perform the 
calibrations. 
Blood pressure measurement 
Arterial blood pressures in the hind limbs were detected by Statham 
pressure transducers (Model P230c, Statham Co., Hato Rey, Puerto Rico) . 
Venous pressure was monitored with a Statham Model PR-23- 10-300 pressure 
transducer . Each pressure transducer strain gauge diaphragm was mounted 
at the hydrostatic lev~l of the hind legs. Pressure calibration values 
from O to 200 cm of water pressure were obtained from a water manometer. 
Arterial pressure channel sensitivities were adjusted so that 200 cm 
of water pressure (147 nvn Hg) produced +1.3 volt output . Venous channels 
had a +1.3 volt output for 50 cm of water pressure {37 rrm Hg). The cal -
ibration procedure included a computer program which converted cm of 
water pressure into mm Hg pressure. Calibration factors were obtained 
from a sequential set of pressures applied to all four arterial pressure 
transducers. The arterial pressure transducers exhibited linear respon se 
to pressures greater than 50 rrm Hg. Very few arterial pressure values in 
the data were less than 50 rrm Hg. 
A separate pressure calibration factor for the low range (less than 
50 nm Hg) was determined for the venous transducer. Each pressure 
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transducer was ca librated by sampling four to five readings across the 
pressure range, and in the range of voltages received by the computer, 
the digitized values were converted to pressures (mm Hg) using the equa -
tion for a straight line (y = mx + b). 
To prevent blood clotting in the pressure, infus ion, or withdrawal 
cannulae , a 0.9% saline perfusion system was utilized . It consisted of a 
Model 1201, Harvard Apparatus Co. peristaltic pump (Harvard Apparat us 
Co., Millis, MA). The pump forced saline through a manifold system into 
all indwelling catheters when they were not being used for pressure mea -
surements or infusions. The system was connected through a four-way 
stopcock to each catheter junction. 
Data Processing 
Pressure and flow information was recorded on a multi -channel poly-
graph (Grass Model 7, Grass Instrument Co., Quincy , MA). Each pressure 
and flow channel of the polygraph was electrically zeroed and balanced at 
the onset of each experiment in order to accurately set baselines for 
pressure and flow measurements. Flow and pressure informat ion available 
at the output of the polygraph amplifiers wa s digitized through a custom-
built analog-to-digital converter and transmitted into a PET 2032 profes -
sional microcomputer (Commodore Business Machines (CBM) Inc., Santa Cla-
ra, CA). Digitized data were stored on 5 1/4" floppy discs by utilizing 
a CBM Model 8050, Dual Disc Drive. A 5-second period of pressure and 
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flow information was sampled at 20 samples per second during each ex-
perimental treatment. 
At the completion of the in vivo portion of each trial, the subject 
was euthanized with sodium pentobarbital (Sleep-Away, 1 ml/5 lb body 
weight, I.V., Fort Dodge Laboratories, Fort Dodge, IA), and the RM con-
taining tissues of the lower hind limbs (muscle, bone, skin and paw) , and 
the lungs and kidneys were isolated and saved for tissue perfusion 
determinations. 
The Radioactive Microsphere Technique (RMT) 
In the RMT, a known number RM of 15µ were injected into the LV of the 
heart for each step in the experiment. Uniform mixing of the RM with 
blood took place in the LV, and the mixture then was transported via the 
systemic arteries to all parts of the body, including the hind limb tis -
sues of interest and the lungs and the kidneys. 
Total lower limb peripheral blood flow (QP) was calculated from the 
sum of the individual tissue perfusion rates for muscle, bone, skin and 
paw. The RMT enabled one to detect not only any change in the rate of 
blood flow to each tissue type, but also in QP and QC to the lower hind 
limb, at each stage during the experiment. 
Arterio-venous (A-V) shunting of the RM was calculated by determining 
RM entrapment in the lungs according to the model cited in Wagner et al ., 
1969). The fraction of shunted blood can be obtained from the following 
formula: 
S = ~. where 
Q 
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S = fraction of blood flow passing through shunts 
Q1 = the quantity (counts per minute) of RM in the lungs 
Q = the counts per minute of the total injected dose 
Q1 represents microspheres which passed through or around systemic capil-
lary beds and which reached the lungs by way of the venous system. 
Kidney blood flow rates were calculated in order to verify that our 
measurements compared favorably with the normal values published by 
Nathanson and Jackson (1975) and Buckberg et al . (1971). 
In each ampule, radionuclide-labelled 15µ microspheres were suspended 
in 10% Dextran to which a few drops of 5% Tween 80 (po lyoxyethylene 80 
sorbitan monooleate) were added by the manufacturer to prevent micro-
sphere aggregation (Heymann et al., 1977) . Five nuclides utilized in 
this study were: scandium (46sc), tin (113s n), strontium (85sr) , niobium 
(95Nb) , and cerium (14l ce) . New England Nuclear Company (Boston, MA) 
supplied the 113sn co ntaining microspheres, and 3M Company (St . Paul, MN ) 
supplied the other four. 
Prior to experimentation, microspheres were systematica ll y examined 
for aberra nt or aggregated RM . Aliquots were examined under a microscope 
at lOOx. A drop of RM was precisely diluted with water; the mixture was 
placed on a slide. An optical measuring grid was used to determine 
average microsphere size. All samples were found to be within the ac-
ceptable range (15µ ~ 5µ) specified by the manufacturers. 
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In order to calculate the correct volume of RM suspension to be in-
jected for each nuclide, the amplitudes of the energy spectrum of each 
isotope were determined on a Model 1282 Compuga11111a Multichannel Pulse 
Height Analyser (LKB Wallac, Gaithersburg, MD). After the spectra were 
determined, the specific spectral regions for counting each isotope were 
established . The number of counts per minute per microsphere were deter-
mined by transferring 10-50 RM onto microscope slide coverslips by streak 
application. The number of RM on each coverslip was counted under a 
microscope . Each coverslip then was fragmented and placed within a 12 x 
75 llTI1 polyethylene culture tube (Number 14-956-10, Fischer Scientific 
Co., Pittsburgh, PA), positioned in the counter and measured for 
radioactivity. 
I11111ediately before injecting RM into the subject, the 5 ml vial con-
taining the RM was mixed vigorously for 10 minutes in a mixer (Model 
1290, Lab Line Instruments Co., Melrose Park, IL) to ensure uniform sus -
pension of the RM (Heymann et al., 1977). 
Reference blood samples (RBS) were employed to check for uniformity 
of RM distribution throughout the circulatory system . RBS collected from 
two widely separated withdrawal sites from the animal should contain 
nearly equal numbers (~5%) of microspheres if adequate mixing and dis-
persal of the RM had occurred. The RBS were withdrawn from two sites, 
the external thoracic artery and the right FA starting 30 seconds prior 
to the onset of RM infusion and ending two minutes post infusion. Blood 
was simultaneously withdrawn at 2.50 ml/min into separate 10 ml glass 
syringes by a dual infusion/withdrawal pump (Model 946, Harvard Apparatus 
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Co. , Inc ., Millis, MA). The collected RBS were transferred to 12 x 75 nm 
polyethylene cul ture vials and counted for radioactivity. 
Wi thdrawing a measurable number of RM at a known , constant flow rate 
also provided a standard for ca l culati ng the fl ow rates of the selected 
tissues and or gans. The calculation of flow using this reference tech-
nique was performed by comparing the number of RM in tissue with the num-
ber of RM collected in the RBS for each RM injection according to the 
following formula: 
Q = Qarxl t where 
1ar 
Q = unknown organ flow in ml/min 
Qar = withdrawal rate for arteria l reference sample in ml /min 
It = radioactivity in tissue or organ sample counter per minute 
( cpm) 
Iar = radioactivity in arterial reference sample (cpm) 
Animals 
Four mongrel dogs approximately two years of age were obtained from 
Laboratory An imal Resources, Iowa State Uni versity . All subjects were in 
excellent health and ranged in weight from 25 to 30 kilograms. 
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Surgical Procedure 
All subjects were anesthetized with 5% sodium pentobarbital (1 ml/kg 
body weight; Fort Dodge Laboratories, Fort Dodge, IA) via injection into 
the cephalic vein. Proper depth of anesthesia was maintained by addi-
tional injections as needed. An endotracheal tube was inserted to main-
tain an open airway. The animals were placed in dorsal recumbancy on a 
warm water heating pad (Model K 20/64N series, Hamilton Aquamatic K 
Module, Hamilton Industries, Cincinnati, OH ) to maintain body tempera-
ture. Lactated Ringers solution with 5% sodium bicarbonate were cons-
tantly administered at a rate of 3.5 ml/min I.V. The electrocardiogram 
was monitored with a Sanborn 780-6A Viso Scope (Hewlett-Packard, Corval-
lis, OR). 
The surgical sites were shaved. A cranio-caudal incision was made in 
the left mid-cervical region along the jugular furrow. The carotid 
sheath was identified and opened, exposing the left carotid artery for 
cannulation. An incision was made in the carotid artery, and a cardiac 
catheter was inserted and advanced towards the heart. The tip of this 
size 7 French catheter was bent by heating the tip to facilitate guiding 
it into the left ventricle. The catheter, attached to a recording pres-
sure transducer, was advanced until a typical left ventricular pressure 
waveform was observed, indicating that the catheter tip had passed 
through the aortic valve into the left ventricle. The exposed portion of 
the catheter then was secured to the carotid artery with a ligature. 
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Through it aortic pressure was detected with a Statham Model 230c pres-
sure transducer and displayed on the Viso Scope, and RM could be injected 
through it into the left ventricle (LV) later in the experiment. 
A skin incision 6 to 8 cm in length was made cranio-caudally midway 
between the point of the left shoulder and the manubrium sterni. After 
retracting the fascia of the thoracic inlet, the external thoracic artery 
was exposed. After applying vascular occluders, an incision was made and 
a can nul a was inserted retrograde for approximately 3 to 4 cm. Through 
this cannula, RBS could be withdrawn. 
An initial skin incision was made extending proximodistally over the 
middle 2/3 of the left medial femoral region. A fascial incision was 
made along the caudal border of the sartorius muscle, parallel to the 
course of, and exposing, the FA and vein (see Plate 1). After these ves-
sels were exposed, pressure cannulae were inserted retrograde into the 
origins of the left proximal caudal femoral artery (PCFA) and the SA for 
measurement of blood pressure in the FA above and below the sites intend-
ed for stenosis and thrombosis. Each cannula tip was advanced proximally 
almost flush with the FA lumen and secured with ligatures. Lower hind 
leg arterial driving pressure, P3 (distal to the FA stenosis) was moni-
tored by inserting a second pressure cannula through the incision in the 
SA in an antegrade direction away from the parent vessel. 
Proximal from the origin of the PCFA, the fascia surround ing the FA 
was dissected free and a noncannulating EMF probe (Model 4, In Vivo 
Metric Systems, Healdsburg, CA) was inserted around the FA to measure 
blood flow (QS) at the stenosis/thrombosis site. A pneumatic vascular 
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occluder (Model OC4, In Vivo Metric Systems, Healdsburg, CA) was similar-
ly emplaced on the FA 2 to 3 cm above the origin of the SA and approxi -
matel y 2 cm downstream from the EMF probe. It was used repeatedly to 
establish zero bl ood flow (baseline setting) in the FA . Before initiat-
ing the experimental treatment, the hyperemic response elicited by oc-
cluding the FA was allowed to disappear. During the 100-S interval of 
the experiment, the FA was clamped midway between the flowmeter and vas-
cular occluder to produce a complete stenos i s . 
To initiate a thrombosis, a vascular incision was made at this same 
site to insert a thrombogenic device into the left FA ( the thrombogenic 
procedure was discussed earlier in this section). 
A similar skin incision was made on the medial surface of the con-
tralateral (right) thigh. The right femoral vein (FV) was isolated 
between the proximal caudal femoral vein (PCFV) and the saphenous vein 
(SV), and a cannula was advanced distally to monitor lower hind limb 
venous blood pressure and to obtain blood for radioimmunoassay (RIA ) pro-
cedures . At approximately the same level as for the venous cannulation, 
a double lumen cannula was inserted into the FA and was advanced pro xi-
mally until its tip resided within the descending aorta at a point just 
below the renal arteries. One lumen of the cannula was used for infusion 
of PGI2 or ACh . The second lumen was used to monitor pressure in the 
descending aorta (PA). 
A hollow polyvinyl tube 15 ll1Tl in length and 2-3 rrm inside diameter 
containing a tightly wound copper coil was inserted into the left FA to 
initiate a thrombosis (Plate 2). 
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Tissue Assay 
Immediately after t he compl etion of each in vivo experiment , the ani-
mals were eutha nized and appropriate RM-containing tissues were collected 
and frozen at _5oc for l ater processing and analysis . Both hind limbs 
were removed below the stifle. Only those hind limb muscles below the 
stifle joint were taken; thigh muscles were carefully excluded . lower 
hind limb tissues were divided into four portions, muscle , bone, skin and 
paw, and frozen for later perfusion analyses . Whole lungs and kidneys 
were also removed for assessment of RM shunting and renal blood flow , 
respectively. 
All tissues were weighed (wet), desiccated in a drying oven (Model 
31543 GCA , Precision Scientific, Chicago , IL), and reweighed (dry) on a 
torsion balance (Model Sc 15, Welch Scientific Co., Chicago , IL) . While 
only wet weights were used for calculations of tissue perfusion, desic-
cated weights were used to ensure that tissue dehydration occurred which 
was adequate to avoid spattering during ashing . Each sample was ashed to 
reduce sample size at 3250C in a muffle furnace (Model Fl1625, Thermolyne 
Corporation, Dubuque, IA) fitted with a temperature control unit to main-
tain a constant temperature (Model 292P , Barber-Colman Co ., Rockford, 
IL). Ashing was continued until samples were reduced to white ash, in-
dicating that all combustible and volatile elements were removed . The RM 
remained in the residue. After ashing, each specimen was very carefully 
transferred to labelled 12 x 75 rrm polyethylene culture tubes within a 
vented , paper-lined hood, approved for use with radioactive materials . 
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Samples were crushed and ground to a fine consistency . A clear plexi-
glass box 2 feet wide by 1.5 feet in height and depth , open in the front 
for access, was utilized during transfer to prevent aerosolized ash from 
contaminating the hood. 
Tubes were transferred to the multichannel ga1TTTia counter and samples 
were measured for radioactivity. Raw counts were analyzed on the mi cro-
computer according to the procedure of Heymann et al. (1977)~ 
GanTna cou nter results were entered into the micrcomputer keyboard to 
calculate individual tissue perfusion and total QPC. Also, signal 
averaging of five second sampling intervals of digitized dynamic EMF flow 
and pressure waveforms was done to obtain mean values. Peripheral and 
collateral bed and stenosis hemodynamic parameters were calculated by 
utilizing mean values of flow, pressures, and radioactive microsphere 
perfusion data (please refer to the Appendi x for a list of formulae ) . 
Previously stated formulae were utilized by the microcomputer to process 
the experimental hemodynamic data stored on disc and to arrive at the 
final parameter results. 
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RESULTS AND DISCUSSION 
The objective of this investigation was to study the effects of 
thrombosis and stenos is upon the hind limb collateral and peripheral cir-
culations and to determine the effects of ACh or PGI2 upon these same 
vascular channels during thrombosis . 
Pressures and flows were measured to establish hemodynamic relation-
ships in the ipsilateral leg (the leg in which the stenosis was applied). 
Contralateral leg peripheral flow (QPC) was determined for comparison 
purposes. The values determined are presented in Tables 1 through 17 and 
Figures 5 through 14. In this set of figures (5-14), the points rep-
resenting the individual data points for each treatment are the important 
features and that the lines connecti ng the points do not reflect actual 
values (during transition from one state to the next). 
Hind Limb Hemodynamics 
The data from this experiment were not pooled, but rather, the indi-
vidual animal responses are discussed separately for three reasons. 
First, the low number of animals in this study (n=4) combined with the 
wide range of subject responses indicated that examination of individual 
responses would most accurately reflect the results . Results were 
analyzed by use of one-way analysis of variance (Snedecor and Cochran, 
1976). We did not find evidence that, during thrombosis, either ACh or 
PGI2 significantly changed QC or QP at the five percent confidence level 
(p < 0.05). Second, the nature of this investigation, with its highly 
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Table 1. Vascular hemodynamics in the hind limbs of dog 10 in each 
treatment period 
Parametera 
QPC 
QP 
RP 
OPP 
QC 
RC 
OPC 
QS 
RS 
OPS 
100% 
34.55 
12.16 
6.23 
75.85 
1.11 
50.40 
59.93 
11. 05 
5.43 
60.02 
0% 
74.79 
11.35 
9.46 
107 .43 
-13.60 
- 3.72 
50.53 
24. 95 
- 0.04 
- 0.94 
Treatment 
Th 
51. 66 
2.07 
40.46 
83. 77 
11.19 
6.84 
76.55 
- 9.12 
- 5.69 
51. 96 
Th+ACh 
49.53 
1.27 
84.72 
107 .59 
- 9.90 
- 4. 68 
46.37 
11.17 
9.55 
106.70 
Definitions of parameters: 
QPC 
QP 
RP 
OPP 
QC 
RC 
OPC 
QS 
RS 
OPS 
Peripheral blood blow in the contralateral leg 
Peripheral blood flow in the ipsilateral leg 
Peripheral resistance 
Driving pressure peripheral bed 
Collateral blood flow 
Collateral resistance 
Driving pressure collateral bed 
Stenosis blood flow 
Stenosis resistance 
Driving pressure stenosis area 
Th+PGI2 
49 .26 
5.15 
15 . 52 
79 .93 
- 1.57 
-48.23 
71 .03 
6.72 
4.98 
33.53 
aFlows expressed in ml/min, resistances expressed in nvn Hg/min/ml, 
pressures expressed in mm Hg. 
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Table 2. Hemodynamic parameters ( b 1 ood pressures) versus experimental 
condition for do9 10 
Stenos is 100% thrombosis - treatment 
Hemodynamic 
parametera 100% 0% None ACh PGI 2 
Pl 112. 34 139 . 02 159 . 60 204.91 148 . 54 
P2 52 . 32 139.96 107 .74 98 . 21 115 . 01 
P3 78.30 108. 71 85 .86 109 . 75 81 . 02 
PA 134.24 159.25 162.41 156 . 12 152.06 
PV 2.45 1.28 2.09 2.15 1.09 
Definitions of parameters: 
Pl Mean arterial blood pressure in the FA proximal to the stenosis 
(driving pressure for flow through stenosis) 
P2 Mean arterial blood pressure in the FA distal to the stenosis 
P3 Mean arterial blood pressure in a branch at the level of the 
DCFA (potent ial collateral blood flow) 
PA Mean arterial blood pressure 
PV Mean venous blood pressure at the FV (venous blood pressure ) 
apressures expressed in mm Hg . 
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Table 3. Vascular hemodynamics in the hind limbs of dog 11 in each 
treatment period 
Parametera 
QPC 
QP 
RP 
OPP 
QC 
RC 
DPC 
QS 
RS 
DPS 
100% 
17.66 
13.02 
3.58 
46 . 73 
24 .45 
2.54 
62.15 
-11.43 
-10.26 
117 .27 
0% 
138 .18 
14.85 
1. 71 
25.41 
-86.41 
- 0.96 
82 .64 
101. 27 
- 0.06 
- 5.25 
Treatment 
Th 
16.14 
22.64 
2. 79 
63 . 27 
33.55 
1. 77 
59 .23 
-10.91 
- 7.20 
78.47 
Th+ACh 
71.09 
13. 54 
3.53 
47 .83 
25.46 
4.67 
72 .11 
-11. 92 
- 8 . 59 
102 .38 
Definitions of parameters: 
QPC 
QP 
RP 
OPP 
QC 
RC 
DPC 
QS 
RS 
DPS 
Peripheral blood flow in the contralateral leg 
Peripheral blood flow in the ipsilateral leg 
Peripheral resistance 
Driving pressure peripheral bed 
Collateral blood flow 
Collateral resistance 
Driving pressure collateral bed 
Stenosis blood flow 
Stenosis resistance 
Driving pressure stenosis area 
Th+PGI2 
20 . 09 
8 .38 
4.17 
34.97 
14.58 
5.36 
78 . 22 
- 6.20 
- 5.47 
33.87 
aFlows expressed in ml/min, resistances expressed in mm Hg/min/ml, 
pressures expressed in mm Hg . 
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Table 4. Hemodynamic parameters (blood pressures) versus experimental 
condition for dog 11 
Stenos is 100% thrombosis-treatment 
Hemodynamic 
parametera 100% 0% None ACh PGI2 
Pl 116. 00 108.98 118.18 115 . 08 118 .28 
P2 - 1.27 114 . 23 39 . 71 12 . 70 84.41 
P3 51. 76 34.57 68.24 51. 79 39.71 
PA 113 . 92 117. 21 127.48 128.90 117 . 93 
PV 5. 03 9.15 4.97 3.96 4.73 
Definitions of parameters: 
Pl Mean arterial blood pressure in the FA proximal to the stenosis 
(driving pressure for flow through stenosis) 
P2 Mean arterial blood pressure in the FA distal to the stenosis 
P3 Mean arterial blood pressure in a branch at the level of the 
DCFA (potent ial collateral blood fiow) 
PA Mean arterial blood pressure 
PV Mean venous blood pressure at the FV (venous blood pressure) 
apressures expressed in mm Hg. 
49 
Table 5. Vascular hemodynamics in the hind limbs of dog 12 in each 
treatment period 
Parametera 
QPC 
QP 
RP 
OPP 
QC 
RC 
DPC 
QS 
RS 
DPS 
100% 
22 . 49 
26 . 57 
2. 80 
74 . 48 
25.53 
1.20 
30.66 
1.04 
15.79 
16.43 
0% 
23.33 
21.53 
3. 09 
66.55 
-15.63 
- 3.34 
52 . 18 
37 .16 
0.39 
14. 68 
Treatment 
Th 
12.18 
30.74 
2.50 
77 .11 
30.24 
1. 60 
48.25 
0.50 
81.18 
40.59 
Th+ACh 
5. 63 
22.08 
3.23 
71.41 
20 . 26 
2. 29 
46.35 
1.82 
13. 62 
24.79 
Definitions of parameters: 
QPC 
QP 
RP 
OPP 
QC 
RC 
DPC 
QS 
RS 
DPS 
Peripheral blood flow in the contralateral leg 
Peripheral blood fiow in the ipsilateral leg 
Peripheral resistance 
Driving pressure peripheral bed 
Collateral blood flow 
Collateral resistance 
Driving pressure collateral bed 
Stenosis blood flow 
Stenosis resistance 
Driving pressure stenosis area 
Th+PGl2 
11.12 
15. 98 
4. 52 
72.36 
15.62 
3.71 
57. 93 
0.36 
46 . 13 
16 . 60 
aFlows expressed in ml/min, resistances expressed in mm Hg/min/ml, 
pressures expressed in mm Hg. 
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Table 6. Hemodynamic parameters (blood pressures) versus experimental 
condition for dog 12 
Stenos is 100% thrombi sos-treatment 
Hemodynamic 
parametera 100% 0% None ACh PGI 2 
Pl 107. 66 105 . 74 125.01 117 . 91 122 .64 
P2 91.23 91. 05 84 .42 93.11 106 . 03 
P3 80 .18 72. 77 82.24 76.17 78 .46 
PA 110. 85 124.96 130.49 122.52 136 .40 
PV 5.70 6.22 5.13 4.75 6.10 
Definitions of parameters: 
Pl Mean arterial blood pressure in the FA proximal to the stenosis 
(driving pressure for flow through stenosis ) 
P2 Mean arterial blood pressure in the FA distal to the stenosis 
P3 Mean arterial blood pressure in a branch at the level of the 
DCFA (potential collateral blood flow ) 
PA Mean arterial blood pressu re 
PV Mean venous blood pressu re at the FV ( veno us blood pressure) 
apress ure s expressed in mm Hg. 
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Table 7. Vascular hemodynamics in the hind limbs of dog 13 in each 
treatment period 
Parametera 
QPC 
QP 
RP 
OPP 
QC 
RC 
DPC 
QS 
RS 
DPS 
100% 
22.75 
13 . 50 
3. 41 
46 .17 
12.10 
8.01 
73.54 
1.40 
28.86 
40.41 
0% 
28 .43 
36.25 
2.36 
85 .71 
-52.69 
- 0.75 
39.55 
88.94 
0.25 
22 . 37 
Treatment 
Th 
17.40 
10.40 
7. 00 
72.90 
-80.85 
- 0.65 
52.69 
91.25 
0.01 
1.18 
Th+ACh 
153.26 
13 . 50 
3.64 
49.18 
12 . 14 
3.47 
42 .07 
1.36 
12 .33 
16 . 78 
Definitions of parameters: 
QPC 
QP 
RP 
OPP 
QC 
RC 
DPC 
QS 
RS 
DPS 
Peripheral blood flow in the contralateral leg 
Peripheral blood fiow in the ipsilateral leg 
Peripheral resistance 
Driving pressure peripheral bed 
Collateral blood flow 
Collateral resistance 
Driving pressure collateral bed 
Stenosis blood flow 
Stenosis resistance 
Driving pressure stenosis area 
Th+PGI2 
62.22 
7.33 
7.03 
51.56 
11. 22 
7. 67 
86.05 
~ 3.89 
-14 . 65 
56 . 97 
aFlows expressed in ml/min, resistances expressed in mm Hg/min/ml, 
pressures expressed in mm Hg . 
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Table 8. Hemodynamic parameters (blood pressures) versus experimental 
condition for dog 13 
Stenos is 100% thrombosis-treatment 
Hemodynami c 
Qarametera 100% 0% None ACh PGI2 
Pl 132.56 132.94 133.00 143.25 134. 83 
P2 115. 78 110.57 131. 81 107 .53 77 .85 
P3 55.04 96.42 85.74 12.48 61 . 95 
PA 103.74 135.97 138.44 142.42 148.00 
PV 12.48 10.70 12.84 9.88 10.39 
Definitions of parameters: 
Pl Mean arterial blood pressure in the FA proximal to the stenosis 
(driving pressure for flow through stenosis) 
P2 Mean arterial blood pressure in the FA distal to the stenosis 
P3 Mean arterial blood pressure in a branch at the level of the 
DCFA (potential collateral blood flow ) 
PA Mean arterial blood pressure 
PV Mean venous blood pressure at the FV (venous blood pressure ) 
aBlood pressures expressed as mm Hg. 
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Table 9. Kidney blood flow (ml/min) in each treatment period 
Treatment 
Subject 100% 0% Th Th+ACh Th+PGI2 -- --
10 458.0 237 .o 29 1.0 183.0 469.0 
11 347.0 210.0 316.0 251.0 424 . 0 
12 395.0 454.0 366.0 344 .0 453 . 0 
13 372 .o 421.0 349.0 391.0 455 . 0 
Table 10. Muscle blood flow (ml/min ) 
each treatment period 
to th~ ipsilateral, left, leg in 
Treatment 
Subject 100% 0% Th Th+ACh Th+PGI2 
10 1. 69 3.35 0. 43 0.27 0. 96 
11 1. 76 1. 93 3.48 2. 77 1.31 
12 7.10 5.56 8 .55 5.06 
____ a 
13 2.31 8.44 1.48 3.89 1.27 
a1ncomplete data. 
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Table 11. Muscle blood flow (ml/min) to the contra lateral, right , leg 
in each treatment period 
Treatment 
Subject 100% 0% Th Th+ACh Th+PGI2 --
10 12.79 21.03 22.83 20.57 5.75 
11 1.68 1. 74 2. 96 23 . 09 2.53 
12 6.69 7.29 3.79 1.15 1. 08 
13 4.73 7.06 4.89 55.50 6.23 
Table 12. Skin blood flow (ml/min) to the contra lateral, right, leg in 
each treatment period 
Treatment 
Subject 100% 0% -- Th Th+ACh Th+PGI2 
10 4. 38 23.00 
____ a 
2. 62 6.01 
11 3. 68 2.98 3.60 4.03 7.78 
12 4.21 3.08 1.68 1. 65 3. 97 
13 4. 68 4.89 2.88 10.85 9.17 
arncomplete data. 
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Table 13. Skin blood flow (ml/min) to the ipsilateral, left, leg in 
each treatment period 
Treatment 
Subject 100% 0% Th Th+ACh Th+PGI2 -- --
10 0.96 0.40 0.27 0.23 0.51 
11 2.42 1.55 1.33 0. 96 0.70 
12 7.39 4.17 3.11 3.61 2. 93 
13 1.23 2.01 0.67 0.70 0.41 
Table 14 . Bone blood flow (ml/min) to the contra lateral, right, leg in 
each treatment period 
Treatment 
Subject 100% 0% Th Th+ACh Th+PGI2 -- --
10 o. 65 1.12 0.54 0.26 10.16 
11 0.89 0.83 1.31 0.78 9 .16 
12 2.48 3.04 1.55 1.41 2.30 
13 2. 60 2.43 0.95 3. 83 15. 09 
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Table 15. Bone blood flow (ml /min ) to the ipsilateral, left, leg i n 
each treatment period 
Treatment 
Subject 100% 0% Th Th+ACh Th+PGI2 --
10 2. 72 2.29 0.55 0.30 1.33 
11 2. 77 2.60 5.15 2.54 2. 14 
12 2. 79 3.60 3. 08 3. 57 5. 50 
13 2.29 4.58 2. 28 2. 43 1.34 
Table 16. Paw blood flow (ml/min) t o the ipsilateral , left , leg in each 
treatment period 
Treatment 
Subject 100% 0% Th Th+ACh Th+PGI2 -- --
10 2. 11 0.36 0.14 0. 08 0.52 
11 1.19 1.87 2. 17 0.89 0.64 
12 1.44 1. 33 2.89 2.46 5.12 
13 1. 71 3. 96 1.51 0.85 1. 01 
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Table 17. Paw blood fl ow (ml/min) to the co ntra lateral , right , leg in 
each treatment period 
Treatment 
Subject 100% 0% -- Th Th+ACh Th+PGI2 
10 0.23 0.1 9 0.12 0.11 11.42 
11 3.48 51.15 1. 65 4. 60 
____ a 
12 0.89 0.91 0.46 0.42 2. 28 
13 1.58 2.17 1.22 1. 94 7. 12 
arncomplete data. 
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invasive experimental design, created considerable "physiologic reac-
tance" (Fry, 1960), treatment responses in the experimental animal which 
would not be consistent with those present in an intact, unoperated sub-
ject, which contributed to the variability of responses. Schwartz et al. 
(1961) reported that dissection of the canine femoral artery stimulates 
vasoconstriction of the distal vasculature. They stated that the sym-
pathetic pathway for peripheral vasoconstriction is associated with vas-
cular trauma. Third, two different types of hemodynamic responses to 
thrombosis were observed in this study . These contributed to the non-
uniformity of the data and may be ascribed to the existence of two 
populations of dogs, arachidonic acid sensitive and arachidonic acid in-
sensitive (suggested by Allen and Clark, 1983). 
Stenos is 
During the stenosis experimental period (100-S ) , a vascular clamp was 
applied to the FA at the previously described site (please refer to the 
Materials and Methods section) to produce 100% stenosis. After measure-
ments were taken, the clamp was removed, and measurements of the normal 
(control) state were taken after the circulation had equilibrated. In 
this way, 100% stenosis was compared with the nonoccluded state . 
In the ipsilateral leg, in dogs 10 and 12, QP was greater and RP was 
less during 100-S than 0-S~ however, the differences were small (Tables 1 
and 5, Figures 6 and 7). 
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QP was slightly less during 100-S in dog 11 (Table 3) and markedly so 
in dog 13 (Table 7) than 0-S. RP was elevated during 100-S in both ani-
mals' ipsilateral legs. 
Peripheral blood flow in the contralateral leg (QPC) was consistently 
depressed by stenosis of the ipsilateral leg in all four subjects (Tables 
1, 3, 5 and 7, Figure 5). This may have been due to the release of 
vasoconstrictor metabolites. 
Subjects 10 and 12 responded differently than expected to 100-S com-
pared to 0-S in that QP was less after release of the occlusion on the FA 
than during 100-S. This reaction could not only be due to changes in 
vasomotor tone of the peripheral vessels over the course of these two 
experimental stages, but also to trauma from the experimentally-induced 
arterial occlusion. Thus, clotting of the red blood cells within the 
peripheral bed of the ipsilateral leg in these subjects may have induced 
the drop in blood flow and RP increase after release of the stenosis. 
QC reversed (Figure 8) and RC declined (Figure 9) after release of 
the stenosis during the 0-S period. These findings are consistent with 
the belief that during occlusion of the FA in the mid-thigh region, flow 
in collateral channels reversed so that the lower hind limb could receive 
blood from the thigh collateral bed via the OCFA and other channels 
rather than the thigh musculature receiving distal femoral artery blood 
as appears frequently to be the normal case. 
Release of the stenosis resulted in a decline in RS in all animals 
(Figure 11) including dog 11 which had a slightly negative resistance 
value due to a negative pressure differential across the stenosis site , 
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which may be the result of a drift in the blood pressure baseline 
calibration . 
The decrease in QS due to stenosis, as compared with the 0-S period, 
indicates that occlusion of the FA interrupted flow through the stenosis 
region (Figure 10). However, had we measured complete occlusion of the 
FA during 100-S, QS should have been zero and RS should have been in-
finite in value (RS=~). The computer averaged values for QS did not 
s 
equal zero nor infinity for RS during 100-S due to slight inaccuracies in 
the digital averaging technique. 
In dog 11, the RS data were negative in value indicating a reverse 
pressure gradient through the stenosis site. P2 was greater than Pl 
during 0- S (Table 4). The return of QS during 0-S to a large positive 
value in part supports the contention that there was experimental error 
in measurement of the pressure gradient across the stenosis. 
Thrombosis 
After 0- S measurements were complete, the thrombogenic device was 
inserted within the FA at the stenosis site. In two out of four sub-
jects , QPC and QP decreased during thrombosis, and in three of four ani-
mals, RP was elevated compared to the 0-S data. 
In dogs 11 and 12, the response to thrombosis was such that QP and 
peripheral perfusion pressure (OPP) in the ipsilateral hind limb was not 
depressed by thrombosis as occurred in the other two subjects (Tables 4 
and 6, Figure 12) . QP and OPP were greater during thrombosis in dogs 11 
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and 12, and RP was depressed less during thrombosis than during stenosis . 
During the control period, RP was greater in dog 12 than during throm-
bosis, and RP in dog 11 was only slightly greater during thrombosis than 
the control value. Subjects 10 and 13 showed a marked decline in QP and 
elevation of RP compared to stenosis. The level of collateralization in 
dogs 11 and 12 may have been greater than in dogs 10 and 13 to account 
for the difference in response to thrombosis. In both dogs 11 and 12, RP 
was less during thrombosis than during stenosis. An elevated QP in both 
subjects which exceeded the increase in OPP during thrombosis accounts 
for the lower RP value during thrombosis compared to stenosis. During 
the control period (0- S), RP was greater in dog 12 than during thrombosis 
(Th). This wa s due to the relatively large QP value in these two 
subjects . 
In dogs 11 and 12 , it was possible that occlusion of the FA with a 
bulldog clamp may have induced vasospasm in the distal peripheral bed 
which could account for the greater decline in flow during 100-S than 
during thrombosis. Thrombosis failed to inhibit QP in dogs 11 and 12; in 
fact, OPP was elevated during thrombosis in both subjects. This may have 
been due to a lack of vascular reactivity. This lack of response to 
thrombosis in the peripheral bed may have been due to the length of time 
the subject was under anesthesia, systemic acidotic conditions, or local 
ischemic metabolites, whi ch compromised vascular responses and resulted 
in vasodilation, possibly irreversible in nature. Had the vascular 
smooth muscle remained responsive along with the receptors and extrinsic 
innervation, the peripheral bed may have vasoconstricted in response to 
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thrombosis. 
Another possibility is that vasodilator agents may have been predomi -
nant in dogs 11 and 12 but not in dogs 10 and 13 so that , despite the 
presence of a thrombus, dilation occurred. 
In dog 10, it appears from the QPC data that vascular response to 
thrombosis was less than durring 100-S in the contralateral leg. Periph-
eral perfusion to the contralateral leg was greater during all periods of 
thrombosis , compared to 100 percent stenosis. This observation suggests 
that vasodilation due to hypoxia and accumulation of metabolic byproducts 
may have occurred in the peripheral bed rendering it insensitive to 
vasoconstrictive metabolites released during thrombosis in this subject. 
The predomi nant effects of thrombosis were decreased QP and QPC (ob-
served in three out of four cases for QPC and two of four cases for QP ) , 
and elevated RP. In dogs 10 and 13 in which QP was inhibited by throm-
bosis, these results imply that vasoactive substances such as serotonin 
or TXA2, released by the thrombus, have vasoconstrictive properties. RP 
with thrombosis was from 2-6x greater than RP during 100-S alone. 
QC and RC were greater during thrombosis than during 100-S in three 
out of four subjects for QC and two of four subjects for RC. Thrombosis 
appeared to be an equal or greater stimulus than stenosis to initiation 
of collateral blood flow. Elevated resistance in the collateral bed may 
have resulted from the release of vasoconstrictor substances from the 
thrombus which would have impeded maximal collateral perfusion to the 
occluded area. However, in all four subjects, PA was elevated to a de-
gree that resulted in increased collateral driving pressure (DPC ) values 
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(Figure 14). Lack of a negative response to thrombosis was apparent in 
dogs 11 and 12; in fact, QS was greater than control (0-5 ) or stenosis 
(100-2) during the Th period. This may indicate that the ability of the 
peripheral circulation to responsd to vasoconstrictive substances 
released during thrombosis may have been compromised. It is more 
probable that dogs 11 and 12 were arachidonic acid insensitive animals, 
compared to dogs 10 and 13. 
In dog 13, the collateral bed failed to respond to thrombosis, but 
there was an incomplete occlusion of the FA at the thrombus site . Incom-
plete thrombosis was indicated by larger QS and smaller RS values com-
pared to the 0-S values. Completely occluding thrombos es did form in 
dogs 10 and 12, as confirmed by elevated resistance and almost nonexis-
tent flow across the stenosis/thrombosis segment of the FA, whi ch we con-
sidered equal to zero. In dog 11, a negative QS value (which should be 
considered equal to zero) was recorded which accounts for the negative RS 
value and is not consistent with the DPS value. The reason for these 
slight inaccuracies is due to the digital averaging scheme utilized for 
the computer. Measurement error and signal averaging of the blood pres-
sure over a nonwhole number of card iac cycles may have caused errors in 
the data. 
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Thrombosis and ACh 
After thrombosis of the FA, ACh was infused into the systemic cir-
culation to determine its effects on the peripheral and collateral cir-
culatory beds of the lower hind limb during thrombosis. Collateral flow 
was inhibited by ACh in dog 11 as QC declined 50% after ACh infusion and 
RC increased 200%. 
Peripheral and collateral perfusion were decreased by ACh in three 
out of four subjects (dogs 10, 11 and 12). QPC, QP, and QC were de-
pressed by ACh infusion during thrombosis. In these animals, it was pos-
sible that, in a systemic response to recirculating vasodilator agents, 
blood was shunted away from the hind limb circulation distal to the 
thrombosis site to other locations where ACh-modulated vasodilation also 
occurred. This "femoral steal'' effect correspond s to observations of a 
"coronary steal" effect in the coronary circulation reported by Flameng 
et al. (1973) and Schaper et al. (1973). This ''steal" effect may occur 
when administration of a vasodilator further compromises blood flow to an 
already malperfused tissue bed by shunting blood flow away fro m that 
region by decreasing peripheral re sistance in other vascular ti ss ue beds. 
Therefore, in dogs 10, 11 and 12, ACh infusion resulted in greater mal-
perfusion of the lower hind limb during thrombosis. An alternative ex-
planation for the observed decrease in QP and QC may be that the ACh 
acted to depress heart rate and contractility, thereby lowering cardiac 
output centrally and depressing hind limb perfusion peripherally. 
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This response was not evident in the other two subjects; dogs 11 and 
13 had 6x and llx increases in QPC, respectively, during ACh treatment. 
QP was also elevated and RP declined dog 13. It appears that in dog 13, 
peripheral perfusion to both ipsilateral and contralateral legs was im-
proved by administration of ACh . Improvement in QP and QPC during ACh 
administration may have been due to lesser degrees of central cardiac or 
peripheral 11 stea1~ effects of ACh. This may be due to a degree of 
vasoresponsiveness of the hind limb beds in these subjects not present in 
dogs 10 and 12 and in the ipsilateral leg in dog 11 . 
The response of the collateral circulation to ACh during thrombosis 
in dog 13 was difficult to assess due to the lack of complete thrombosis . 
But since QS approached zero and RS values were consistent with values 
obtained during 100-S, it appears that during this experimental period 
(TH + ACh) the FA finally was completely occluded by thrombus. 
Hind limb collateral perfusion during ACh administration in dog 10, 
characterized by negative values for QC and RC, was absent . That is, the 
thigh appeared to be receiving blood from the DCFA in quantity similar to 
that of the 0-S period. This observation i s difficult to reconcile but 
may be a result of a discrepancy in the portion of the circulation model 
depicting the pressure gradient across the collateral bed. 
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Thrombosis and PGI2 
PGI2 improved QPC during thrombosis as did ACh in dog 11 and 13. In 
dogs 10 and 12 , the response to PGI2 and ACh was similar in that both 
vasodilator drugs inhibited QPC during thrombosis. However, this inhibi-
tion was negligible except in dog 12, in which ACh produced a 50% decl ine 
in QPC . 
The reaction of t he ipsilateral leg to PGI2 infusion was different 
from that in the contralateral leg. QP declined and RP was elevated in 
three out of four animals in response to PGI2 , and in each, PGI2 promoted 
peripheral perfusion to a lesser degree than ACh . In dog 10, QP was ele-
vated 4x during Th + PGI2 over Th + ACh. In the individual (dog 13) in 
which ACh was minimally effective in increasing QP, PGI2 depressed QP, 
and RP was increased. It appears that although the value for RP was 
similar to that of the Th period, the equality was due to the fact that 
both QP and OPP declined during PGI2 infusion. 
Compared to the ACh treatment, QC declined and RC increased with PGI2 
infusion during thrombosis in all four subjects. PGI2 and ACh were both 
ineffective in promoting collateral circulation in these animals. The 
"femoral steal'' effect , previously mentioned in reference to ACh ad-
ministration , may also have resulted from systemic effects of PGI2 on 
vascular beds . Both ACh and PGI2 thus may have shunted blood away from 
the thigh collateral bed during thrombosis and increased malperfusion of 
the tissues distal to the arterial thrombosis . 
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Negative values for QC and RC expressed for the Th + PGI2 period in 
dog 10 suggest negative collateral flow. However, for dog 11, a negative 
QS value seems invalid during 0-S because the positive gradient discounts 
the possibility of negative QS. Therefore, the resultant negative RS 
values obtained during the other experimental periods suggest that QS may 
have been measured incorrectly. 
Ranges of Tissue and Organ Perfusion Rates 
Kidney blood flow 
Total kidney blood flow measured by he RMT in the four dogs ranged 
between 183-469 ml/min (Table 9). This range compared favorably with RMT 
values reported by Nathanson and Jackson (1975). They found that blood 
flow to the kidneys ranged from 200-800 ml/min in the dog. The agreement 
of our data with their published information suggests that we had accu-
rately measured blood flow with the RMT and that our dogs had reasonable 
cardiac outputs and renal blood flows. 
Muscle blood flow 
Lower hind limb muscle perfusion during 0-S averaged 4.89 ml/min in 
the ipsilateral leg (Table 10) and 9.28 ml/min for the contralateral leg 
(Table 11). Kane and Grim (1969) reported an average muscle blood flow 
of 5.6 ml/min. Their studies were conducted on noninstrumented subjects 
using an isotope washout technique. In light of the increased phys-
iologic reactance of our invasively instrumented subjects, our results 
compare to a reasonable degree. In our preparation, the ipsilateral leg 
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requi red extensive surgical intrusion. There was a lesser degree of in-
vasiveness in the contralateral leg. Our sub jects were not heparinized 
in order to permit thrombosis to develop in the FA. Therefore, due to 
the invasivity of the preparation, embolization at the micro and macro 
levels may have partially impeded perfusion to the ipsilateral limb. 
That is, surgical trauma may have stimulated vasoconstriction and distal 
muscle ischemia, thus inhibiting lower hind limb blood flow. 
Skin blood flow 
During 0-S, skin perfusion rates ranged from 2. 98-23.00 ml/min in the 
contralateral leg (Table 12) and 0.40-4.17 ml/min in the ipsilateral leg 
(Table 13). Skin blood flow ra tes were lower in the ipsilateral leg. 
Again, this may have been due to the high degree of surgical trauma to 
that leg. Kane and Grim (1969 ) stated that the average blood flow to the 
skin was 8.4 ml /min, which wa s comparable to what was measured in this 
study for the contralateral leg. The range of ski n blood flow rates mea -
sured in this experiment is reasonable as skin blood flow rates may vary 
greatly with the physiologi cal state of the animal and are affected by 
depth of anesthesia, ambient temperature, and release of vasoactive 
agents . 
Bone b 1 ood fl ow 
Contralateral leg blood flow rate to the bone tissue averaged 1.86 
ml/min (Table 14) and 3.28 ml/min in the ipsil ateral l eg (Table 15) 
during 0-S. Gross et al . (1981) sta t ed that in the dog, bone blood flow 
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may vary from 2-30 ml/min. Our results fall within the range of pre-
viously reported data for bone blood flow. It appears that the ip-
silateral leg had higher bone blood flow values than did the con-
tralateral leg . The greater su rgi ca l trauma in the ipsilateral leg has 
been shown to depress lower hind limb blood flow in other tissues, 
however bone blood flow to the more invasively prepared ips i latera l leg 
was greater than the contralateral leg. The invasiveness of the prepara -
tion of the ipsilateral limb did not inhibit flow to the bone more than 
in the contralateral limb, as it had in other tissues . This may have 
been due to physiological reasons not readily discernible . However , the 
bone blood flow measurements were at the low end of the normal range, and 
this may be attributed to anesthesia, the long duration of the experi -
ment, or the high degree of surgical invasiveness. 
Paw blood flow 
Blood flow to the paw during the control period (0-S ) in the ip-
silateral leg ranged from 0.36 to 3. 96 ml/min (Table 16) . Contralateral 
leg paw blood flow was calculated to be 0.19 to 2.17 ml/min during the 
control period in three out of four animals (Table 17 ) . A value of 51 . 15 
ml/min was determined for dog ll's paw blood flow. This value seems ex-
ceptionall y high compared to the values recorded for the other subjects, 
and the reason for this outlying value is not readily apparent. 
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Femoral Shunting ( 11Steal 11 ) 
Ischemia-induced intrinsic release of vasoactive substances may have 
augmented the shunting of blood away from already malperfused regions 
during vasodilator administration. The infusion catheter for vasodilator 
administration was positioned within the terminal aorta so as to expose 
the beds fed by the terminal branches of the aorta first to the infu-
sates. Upon recirculation, the remainder of the circulatory beds of the 
body would be exposed to any intact agonists. It is possible recirculat-
ing ACh may have diminished cardiac output in some cases. PGI2 degrada -
tion is not complete in the lungs enabling it to reach other tissue beds. 
The thigh region may have been relatively more responsive than the lower 
hind limb to the vasodilators since it was subjected to less surgical 
trauma. Thus, it and other systemic nutritional beds could have been 
more responsive to vasodilator agents and more able to maintain perfusion 
rates. Blood flow may have been directed primarily to the thigh muscula-
ture's arterio-capillo-venous channels before reaching the lower leg. 
The lower hind limb may have been made insensitive to the actions of 
agents such ACh or PGl2 due to the vasoconstrictive effects of serotonin 
and/or TXA2, which may override the actions of the vasodilators during 
th rombot ic occlusion. Schaub et al . (1977a) found that serotonin was 
released during arterial thrombosis and postulated that TXA2 was also 
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associated with vasoconstriction which occurred during thrombosis. Non -
ischemic areas responsive to the vasodilators could achieve greater de-
creases in vascular resistance and , thus, increased flow. A nonrespond-
ing, constricted , or thrombotically-occluded and maximally dilated, cir-
culatory bed would maintain its relatively high resistance, with resul -
tant shunting of blood to other dilated areas. 
Percent Shunting of Radioactive Microspheres (RM) 
Shunting of RM via arterio-venous channels which would pass the 
nominal 15µ spheres was determined by dividing the number of RM reaching 
the lungs by the total RM dose injected into the left ventricle. In our 
study , we found that from 1.2 to 4.8 percent of the RM dose was shunted 
into the lungs . Kaihara et al . (1968) reported 5 to 10 percent shunting 
into the lungs with 15µ RM in dogs. Our results show that excess shunt-
ing did not occur in this study, supporting the validity of the data for 
the parameters measured by the RMT. 
Total Hind Limb Blood Flow 
Blood flow to the lower hind limbs was ca l culated by summing the four 
tissue fiow rates . Flow to the ipsilateral leg for dogs 10, 11 , 12 and 
13 during 0-S were 24.95, 101.27, 37.16 and 88 .94 ml/min , respec tively; 
and for the contralateral leg, 74.79, 14.85, 23 . 33 and 28.43 ml /min, 
respectively. Coffman (1966 ) measured femoral artery inflow for the ca -
ni ne hind limb , and the results averaged 36 .8 ml/min . Venous outflow was 
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determined by Kane and Grim (1969), and the results for two separate 
studies measured hind limb blood flow to be 45.8 ml/min and 74.2 ml/min. 
Our values compare well with previously documented values. 
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SUMMARY AND CON CLUSIONS 
The objectives of this research were to compare the capacity of acute 
stenosis and thrombosis of the FA to affect QC and to determine if QC 
could be enhanced by infusion of the vasodilators ACh and PGI2. In order 
to validate the experimental model for this investigation, pilot trials 
were initiated on nine dogs to establish seve ral procedures new to this 
laboratory: 
1. The RMT was successfully introduced for measu rement of QP, kidney , 
and hind limb tissue blood flows. 
2. Computer programs were implemented for data acquisition , storage, and 
calculation of parameters. 
3. A copper coil device which induced an intra -arterial thrombus to 
gradually form was employed. 
The actual experimentation was conducted on four mongrel dogs from 25 
to 30 kg in weight. Each animal wa s subjec ted to five experimental 
treatments; they were, in sequence, 100-S, 0-S, Th, Th + ACh, and 
Th+ PGI2. Hind limb collateral and peripheral hemodynamics were mea -
sured during all treatment periods. 
After hemodynamic measurements were made during the initial treatment 
period (100-S), the stenosis was removed, and cha nges in peripheral, col -
lateral, and stenosis hemodynamics were observed . QPC increased only 
slightly in dogs 12 and 13, but in dogs 10 and 11, QPC was markedly ele-
vated after release of the stenosis (during 0-S) . In the l atter two sub-
jects, stenosis of the ipsilateral leg greatl y inhibited periphe ral blood 
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flow in the contralateral limb. The inhibition of QPC could have been 
due to vasospasm in the contralateral leg in response to the vascular 
trauma of clamping the ipsilateral FA during 100-S (Schwartz et al., 
1961). 
QP was inhibited during 100-S in dog 13; again, this may have been 
caused by distal vasoconstriction associated with the vascular trauma of 
clamping the FA during 100-S. The increase in QP following the release 
of the stenosis in dog 13 may have been due to another factor, reactive 
hyperemia. The initial phase of the reactive hyperemia response is 
characterized by vasodilation and increased blood flow to a previously 
occluded site after release of the occlusion (stenosis) if the vascular 
smooth muscle can respond to the build-up of local catabolites. After 
the catabolites were flushed out and local oxygen levels restored, then a 
secondary vasoconstriction would result. However, this response was ab-
sent in the other three subjects, and this lack of response in these sub-
jects is consistent with the small change in RP between the 100-S and 0-S 
periods. The viability of the vascular smooth muscle may have been com-
promised, accounting for the lac k of response to stenosis in the periph-
eral bed in dogs 10, 11, and 12. 
It is interesting to notice that the small increase in RP during 0-S 
may have prevented greater QP in dog 10 despite the concurrent increase 
in OPP. Dog 13 exhibited an increase in OPP and QP, and RP declined 
slightly during 0-S. Collateral blood flow and resistance declined 
during this period, although DPC values were inconsistent between 
animals. 
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There were two different responses to thrombosis. This may have been 
du e to a lack of viability of the vascular smooth muscle in nonresponsive 
subjects, or more probably due to a lack of sensitivity of the vascular 
smooth muscle to release of arachidonic acid metabolites during throm-
bosis. According to Allen and Clark (1983), there may exist two discrete 
canine populations, arachidonic acid sensitive and arachidonic acid in-
sensitive animals. This may account for the two different responses to 
thrombosis in our study. In subjects which QP and OPP were elevated, RP 
was unchanged and OPC declined (dogs 11 and 12). The second type of 
response to thrombosis in dogs 10 and 13 was characterized by depressed 
QP and OPP, a larger RP value, and elevated OPC. In subjects whose pe-
ripheral circulation was inhibited by thrombosis, more blood may have 
been directed towards the collateral bed in response to thrombosis in 
dogs 10 and ·13, as shown by the larger OPC values. All subjects consis -
tently had greater QC, with little change in RC, while QPC declined 
during thrombosis . 
ACh appeared to improve QC in only one subject (dog 13) , while i t 
depressed QC slightly in the other three. The increased QC in dog 13 is 
not valid; the reason for the apparent increase from the Th to the 
Th + ACh period is not due to any ACh effect but is due to a lac k of com-
plete thrombotic occlusion of the FA during Th as evidenced by the large 
QS value . QS declined during the Th+ ACh period, indicating that com-
plete occlusion of the FA occurred at that time, an event which provided 
the stimulus for collateral blood flow which was absent in the Th period. 
ACh infusion inhibited QC in those three subjects in which a complete 
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thrombotic occlusion formed during the Th period. RC declined and RP 
increased due primarily to a decrease in DPC and elevation of OPP which 
suggests blood flow may have been directed away from the collateral bed 
due to a peripheral "steal" effect in which infusion of the vasodilator 
further compromised blood flow by shunting flow away from that region . 
QPC was improved by ACh in two subjects (dogs 11 and 13), while a 
slight decline occurred in dogs 10 and 12. QP was also improved in dog 
13, and RP declined slightly. PA was slightly elevated in dogs 11 and 
13, whereas dogs 10 and 12 had slightly depressed PA after ACh infusion, 
which suggest s that cardiac output may have been depressed by ACh in dogs 
10 and 12 but not in dogs 11 and 13, accounting for their elevated QPC 
values. This may also be due to lesser peripheral "st~al" or a degree of 
vasoresponsiveness not present in the contralateral hind limb beds of 
dogs 10 and 12 . 
PGI2 infusion was ineffective in improving QC over Th or Th + ACh 
levels in this trial, although DPC values were elevated over Th+ ACh 
levels in all ·subjects and were greater than Th values in all subjects 
but dog 10. In subjects 10 and 13, it is interesting to note that both 
the Th and the Th + PGI2 treatment periods produced increases in QPC. 
This may indicate a greater sensitivity to arachidonic acid and its 
metabolites in these subjects than in dogs 11 and 12 . However, QC was 
not improved in dogs 10 and 13, although the elevation of DPC with infu-
sion of PGI2 was more pronounced in dogs 10 and 13 than in dogs 11 and 
12. The slight increase in RC during PGI 2 infusion (which occurred in 
all subjects except dog 10) may have prohibited elevation of QC . 
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Only dog 10 had greater QP and depressed RP and RC during PGI2 infu-
sion than in previous Th and Th+ ACh periods, despite a decline in OPP. 
QPC values for dogs 11 and 13, which were elevated during ACh infu-
sion, declined with infusion of PGI2. QPC in dog 13 remained greater 
during Th + PGI 2 than during the Th period; however, PGI2 produced no 
significant difference in the other three subjects . 
In conclusion, we we re unable to demonstrate any significant dif-
ference with one-way analysis of variance (p < .05) in the four subjec ts 
between the peripheral and co llateral effects of stenosis or thrombosis, 
and neither ACh nor PGI2 were significantly effec tive in promoting CF 
during thrombosis ( p < . 05). 
There were problems in obtaining uniform response to our experimental 
treatments due to the high de gree of surgi cal invasiveness of the animal 
preparation . The occurrence of vasospasm, spontaneous intravascular 
thrombosis, and release of vasoactive substances may have occurred due to 
man ipulation at the surgical s ites. The validity of data obtained from 
such an extensively instrumented animal model may be questioned in l ight 
of the divergent nature of some of the results . 
The smaller number of subjects (n=4 ) and the high degree of indi -
vidual variation in this st udy made interpretation of trends difficult . 
The existence of arachidonic acid sensitive and arac hidoni c ac id insensi-
tive subjects in this study could have resulted in t he two different ob-
served responses to thrombosis and could have further impeded interpreta -
tion of the ACh and PGI2 treatments . 
88 
Simplification of the model in this investigation into a less inva-
sive preparation would be necessary to permit evaluation of more normal 
physiological responses. Future refinements could also include the use 
of EMF probes which are electronically zeroed to prevent baseline drift. 
Baseline drift made measurement of QS zero flow difficult and resulted in 
erroneous negative values for QS and RS in our experimental data. 
Finally, our choice of using P3 as an estimate for collateral bed 
downstream pressure (and lower hind limb driving pressure) may not have 
been appropriate to measure the hemodynami c events occurring in the col-
lateral bed. Nevertheless, P3 appeared to be the only accessible anatom-
ic site for tapping into the common point between these two arterial 
beds. Further experiments would be warranted to define the optimum 
placement of a blood pressure cannula with respect to measu rement of low-
er hind limb and collateral bed properties. 
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LI ST OF FORMULAE 
DPC = PA-P3 
OPP = P1-P2 
DPS = P2-PV 
PA-PV = QP(RP + RS· RC) 
RS+RC 
Q( RMT) = Qar ·It 
Iar 
QP 
QS 
QC 
RC 
RP 
RS 
s 
y 
Q =un known organ flow in ml/min 
Qar = flow of arterial reference sample in ml/min 
It = amount of radioactivity or cpm in tissue or organ sample 
Iar = amount of radioactivity or cpm in arterial reference sample 
= QS + QC 
= QP QC 
= QP QS 
PA - P3 = 
QC 
P - PV 
= 2 
QP 
= pl - p2 
QS 
= Ql 
Q 
S = fraction of blood flow passing through shunts 
Q1 = the quantity (cpm) of RM in the lungs 
Q =the total injected RM dose 
= mx + b 
y = y coordinate 
m = slope of the 1 i ne 
x = x coordinate 
b = y intercept 
